Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples